CD4 and neoplasm: Moreover, CXCL9 was significantly increased in cutaneous tumor patients, and played a critical role in CXCR3+ T cells (including CD4+ and CD8+ T cells) and NK‐mediated tumor immune‐surveillance and suppression 71, 72.